Fidelity Advisor Freedom 2015 Fund - Class A
FFVAX
NASDAQ
| Weiss Ratings | FFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Reward Grade | D+ | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | FFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Fidelity Investments | |||
| Manager/Tenure (Years) | Andrew J Dierdorf (15), Brett F. Sumsion (12), Cait Dourney Earle (1), 1 other | |||
| Website | http://www.institutional.fidelity.com | |||
| Fund Information | FFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Fidelity Advisor Freedom 2015 Fund - Class A | |||
| Category | Target-Date 2015 | |||
| Sub-Category | Target Date | |||
| Prospectus Objective | Asset Allocation | |||
| Inception Date | Nov 06, 2003 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 0.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | 0.06 | |||
| Back End Fee | -- | |||
| Dividends and Shares | FFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 2.53% | |||
| Dividend | FFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.67% | |||
| Asset Allocation | FFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 1.23% | |||
| Stock | 40.35% | |||
| U.S. Stock | 20.18% | |||
| Non-U.S. Stock | 20.17% | |||
| Bond | 58.06% | |||
| U.S. Bond | 51.21% | |||
| Non-U.S. Bond | 6.85% | |||
| Preferred | 0.05% | |||
| Convertible | 0.01% | |||
| Other Net | 0.30% | |||
| Price History | FFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.44% | |||
| 30-Day Total Return | -0.26% | |||
| 60-Day Total Return | -2.29% | |||
| 90-Day Total Return | -2.20% | |||
| Year to Date Total Return | 3.57% | |||
| 1-Year Total Return | 4.66% | |||
| 2-Year Total Return | 15.70% | |||
| 3-Year Total Return | 32.20% | |||
| 5-Year Total Return | 15.44% | |||
| Price | FFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | FFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | -- | |||
| 1-Month Low NAV | $11.08 | |||
| 1-Month High NAV | $11.16 | |||
| 52-Week Low NAV | $10.83 | |||
| 52-Week Low NAV (Date) | Mar 27, 2026 | |||
| 52-Week High NAV | $11.54 | |||
| 52-Week High Price (Date) | May 06, 2026 | |||
| Beta / Standard Deviation | FFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.96 | |||
| Standard Deviation | 6.65 | |||
| Balance Sheet | FFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 384.01M | |||
| Operating Ratios | FFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.74% | |||
| Turnover Ratio | 18.00% | |||
| Performance | FFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 13.63% | |||
| Last Bear Market Total Return | -9.37% | |||